O1 Faecal volatile organic compounds in paediatric inflammatory bowel disease

Belnour, Salma, Slater, Rachael ORCID: 0000-0001-9765-6978, Auth, Marcus KH ORCID: 0000-0002-9381-6994, Muhammed, Rafeeq, Spray, Christine, Wang, Duolao, Probert, Chris ORCID: 0000-0003-0477-6714 and Allen, Stephen (2021) O1 Faecal volatile organic compounds in paediatric inflammatory bowel disease In: Plenary.

PDF 01 Faecal VOCs in pIBD.pdf - Other Download (224kB) | Preview

Abstract

Faecal volatile organic compounds (VOCs) result from the metabolism of the intestinal mucosa, gut microbiota and the environment. Profiling of faecal VOCs in children with different IBD sub-types and disease distribution and activity may shed light on underlying disease mechanisms. We assessed faecal VOCs by gas chromatography-mass spectrometry in a prospective, observational study of children with suspected inflammatory bowel disease (IBD) attending 3 specialist clinics. We tested whether the abundance of faecal VOCs differed according to IBD versus other gastrointestinal disorders, IBD subtype and response to treatment in IBD. We characterised faecal VOCs in 132 children in whom IBD was diagnosed and 132 non-IBD controls. 162 (61.4%) were boys. Mean age was 12.2 years (SD 3.0). In total 214 (81.1%) were white, 35 (13.3%) were Asian and 15 (5.7%) of other ethnic background. There were 78 (29.5%) children with Crohn’s disease (CD), 38 (14.4%) with ulcerative colitis (UC) and 16 (6.1%) IBD-unclassified. The most common diagnosis in controls was a functional gastrointestinal disorder. The mean abundance of 16 VOCs was significantly lower in IBD than controls whereas phenol and propan-1-ol were higher in IBD (p=0.001). Some short chain fatty acids (butanoic, pentanoic and hexanoic acids) were lower in IBD than controls (p<0.03). The two compounds that were more abundant in IBD than control (propan-1-ol and phenol) returned to control levels post-treatment (figure 1). Box and whisker plots of propan-1-ol and phenol Within IBD, the subtype (CD versus colitis (UC and IBD-unclassified)) described a small amount of variation (3%, p=0.006), with three faecal VOCs (6-methylhept-5-en-2-one; benzaldehyde; 4-methylphenol) significantly different in abundance between CD and colitis (t-test, p<0.05). Propan-1-ol and phenol, higher in abundance in IBD than controls and returning to control levels post-treatment, may indicate abnormal amino-acid metabolism in pre-treatment IBD; phenol may be pro-inflammatory. Further analysis of VOCs may provide insights into underlying disease mechanisms in paediatric IBD.

Item Type:	Conference Item (Unspecified)
Uncontrolled Keywords:	3205 Medical Biochemistry and Metabolomics, 32 Biomedical and Clinical Sciences, Digestive Diseases, Pediatric Research Initiative, Crohn's Disease, Nutrition, Inflammatory Bowel Disease, Autoimmune Disease, 2.1 Biological and endogenous factors, Oral and gastrointestinal, 3 Good Health and Well Being
Depositing User:	Symplectic Admin
Date Deposited:	18 Mar 2024 15:05
Last Modified:	09 Oct 2026 04:42
DOI:	10.1136/flgastro-2021-bspghan.1
Related Websites:	Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3179601
Disclaimer:	The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.